Read the docs
TI-2022-12516 Aliases CVE-2022-30277GHSA-r2qv-r4vq-j8mm

BD Synapsys™ – Insufficient Session Expiration

Priority LOW 25CWE-613Published · Updated

Key facts

Attack vector
Physical
Privileges required
Low
User interaction
Required
Attack complexity
Low
Impact type
Security bypass
Confidentiality · integrity · availability
High · High · None
Fix status
No fix listed

Attack profile from CVSS 3.1 · CNA. Fix status from CNA. Impact type from CWE-613.

Summary

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

Why it matters now

EPSS 0.00232 14th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

Not available: CISA has not published SSVC decision points for this record.

Affected products

VendorProductAffected versionsFixed inStatusSource
Becton, Dickinson and Company (BD)BD Synapsys™4.20 – 4.30—No fix listedCNA

CPE configurations NVD · 3

CPEVersionsRoleVendor
cpe:2.3:a:bd:synapsys:4.20:-:*:*:*:*:*:*4.20VulnerableBecton, Dickinson and Company (BD)
cpe:2.3:a:bd:synapsys:4.20:sr1:*:*:*:*:*:*4.20 sr1VulnerableBecton, Dickinson and Company (BD)
cpe:2.3:a:bd:synapsys:4.30:*:*:*:*:*:*:*4.30VulnerableBecton, Dickinson and Company (BD)

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2022-30277
  2. 2026-10-03 Alias added: GHSA-r2qv-r4vq-j8mm

References

Sources